Trial intelligence / Profile preview

Hydrocortisone Pre-treatment for Protamine Sulfate Side Effects in Cardiac Surgery

NCT04435912Phase 1Completed

Sponsor
University of Jordan
Start
Jul 2019
Primary completion
Apr 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of hydrocortisone in hypotension (2 arms), sponsored by University of Jordan. Primary endpoint: Systolic, Diastolic, and Mean Arterial Pressure at 30 months. Started Jul 2019; status: completed.

02

Drugs

hydrocortisone
03

Conditions

hypotension

Beyond the preview

Go deeper on NCT04435912.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04435912.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call